Cancer Drug Resistance

Loss of HER2 in breast cancer: biological mechanisms and technical pitfalls

Stefania Morganti, Mariia Ivanova, Emanuela Ferraro, Liliana Ascione, Grazia Vivanet, Giuseppina Bonizzi, Giuseppe Curigliano, Nicola Fusco, Carmen Criscitiello

View Full-Text Download PDF

Page 971-980

Hot Keywords

Table of Contents (13 articles)

Drug and apoptosis resistance in cancer stem cells: a puzzle with many pieces

Mechanisms of neratinib resistance in HER2-mutant metastatic breast cancer

Improving HER2 testing reproducibility in HER2-low breast cancer

Cancer-associated fibroblasts as accomplices to confer therapeutic resistance in cancer

Tyrosine kinases in KMT2A/MLL-rearranged acute leukemias as potential therapeutic targets to overcome cancer drug resistance

Tackling heterogeneity in treatment-resistant breast cancer using a broad-spectrum therapeutic approach

Discovery of the inhibitor of DNA binding 1 as a novel marker for radioresistance in pancreatic cancer using genome-wide RNA-seq

Aberrant Notch signaling in gliomas: a potential landscape of actionable converging targets for combination approach in therapies resistance

Perspectives of metal-organic framework nanosystem to overcome tumor drug resistance

Loss of HER2 in breast cancer: biological mechanisms and technical pitfalls

Cancer resistance to immunotherapy: What is the role of cancer stem cells?

Association between genome-wide epigenetic and genetic alterations in breast cancer tissue and response to HER2-targeted therapies in HER2-positive breast cancer patients: new findings and a systematic review

The role of antiangiogenic monoclonal antibodies combined to EGFR-TKIs in the treatment of advanced non-small cell lung cancer with activating EGFR mutations: acquired resistance mechanisms and strategies to overcome them

Actions for selected articles

CANCER DRUG RESISTANCE

Navigation

follow us

OAE Publishing Inc.

OAE JOURNALS

FOLLOW OAE